Skip to content

Calumet, Inc. CLMT Net investment gains (losses)

Net investment gains (losses) at other companies

Icahn Enterprises logo
Icahn EnterprisesIEP

Other financials

Income statement

See full
Revenue$1.0B+3.6%
Gross profit-$87.5M-7.5%
Operating income-$171.3M-252%
Net income-$317.0M-95.7%
EPS (diluted)-$3.64-94.7%

Balance sheet

See full
Cash & equivalents$138.6M+12.3%
Total debt$2.3B-9.0%
Total equity-$1.0B-21.0%
Total assets$2.8B-2.4%

Cash flow

See full
Operating cash flow-$86.2M-194%
CapEx$13.2M-25.0%
Free cash flow-$99.4M-112%

Valuation

See full
Market cap$2.86B+185%
Enterprise value$5.06B+50.3%
P/S0.7×+0.4×

Profitability

See full
Gross margin5.8%+4.1pp
Operating margin4.8%
Net margin-4.5%-1.4pp
FCF margin0.1%

Returns & leverage

See full
Return on equity19.8%
Debt / equity-2.2×
Current ratio-0.1×

Where this comes from

Reported directly by Calumet, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnDerivativeInstrumentsNetPretax.

The official record: Calumet, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Calumet, Inc.'s net investment gains (losses).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Calumet, Inc.'s net investment gains (losses)?
Calumet, Inc. (CLMT) reported net investment gains (losses) of -$115.4M in Q1 2026.
How has Calumet, Inc.'s net investment gains (losses) changed year-over-year?
Calumet, Inc.'s net investment gains (losses) decreased by 1502.8% year-over-year, from -$7.2M to -$115.4M.
What is the long-term trend for Calumet, Inc.'s net investment gains (losses)?
Over 2 years (2022 to 2025), Calumet, Inc.'s net investment gains (losses) has grown at a -67.4% compound annual growth rate (CAGR), from -$81.7M to $8.7M.
What does net investment gains (losses) mean?
Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.